Products & Services · Deferred revenue recognized
Paxlovid and Comirnaty — Deferred revenue recognized
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2026
Last reportedQ1 2026
How to read this metric
An increase indicates successful fulfillment of product delivery obligations and active revenue generation from the existing backlog.
Detailed definition
This represents the amount of previously deferred revenue that has been recognized in the income statement during the cu...
Peer comparison
Comparable to 'Revenue Recognized from Deferred Revenue' or 'Amortization of Contract Liabilities' across the broader healthcare and life sciences industry.
Metric ID:
pfe_segment_paxlovid_and_comirnaty_deferred_revenue_recognizedHistorical Data
1 periods
| Q1 '26 | |
|---|---|
| Value | $58.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's paxlovid and comirnaty — deferred revenue recognized?
- Pfizer (PFE) reported paxlovid and comirnaty — deferred revenue recognized of $58.00M in Q1 2026.
- What does paxlovid and comirnaty — deferred revenue recognized mean?
- The amount of previously collected advance payments that has now been officially recorded as revenue.